• LAST PRICE
    0.7798
  • TODAY'S CHANGE (%)
    Trending Down-0.0214 (-2.6710%)
  • Bid / Lots
    0.7799/ 8
  • Ask / Lots
    0.7800/ 10
  • Open / Previous Close
    0.8023 / 0.8012
  • Day Range
    Low 0.7720
    High 0.8100
  • 52 Week Range
    Low 0.3600
    High 1.9200
  • Volume
    816,230
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.8012
TimeVolumeVERU
09:32 ET2114240.798
09:34 ET3850.797321
09:36 ET1000.8028
09:38 ET2000.789
09:39 ET11000.805954
09:41 ET2000.79
09:43 ET8110.81
09:45 ET1000.8005
09:48 ET3080.8
09:50 ET1000.7999
09:52 ET2000.7945
09:56 ET1000.7999
09:57 ET1000.7999
09:59 ET1000.7999
10:01 ET4500.7998
10:06 ET1000.7998
10:08 ET2000.7998
10:10 ET1000.7998
10:12 ET4500.795
10:14 ET2000.8
10:15 ET45770.7891
10:17 ET14000.79
10:21 ET21000.7893
10:24 ET1000.7924
10:26 ET8600.7893
10:28 ET1000.7925
10:30 ET5000.7925
10:32 ET1000.7955
10:35 ET15800.7925
10:37 ET6000.79245
10:51 ET1000.7955
10:55 ET5780.7896
10:57 ET6000.7948
11:00 ET1000.7918
11:02 ET1000.794
11:04 ET1750.7895
11:06 ET2000.794
11:09 ET1000.794
11:11 ET1000.791
11:13 ET1000.7926
11:15 ET2500.79
11:18 ET7080.7984
11:20 ET6000.7908
11:22 ET1000.7984
11:26 ET1000.7996
11:29 ET1000.7996
11:31 ET10000.7909
11:33 ET11000.7909
11:36 ET18380.7911
11:38 ET1000.7942
11:40 ET1000.7996
11:45 ET1000.7996
11:47 ET3000.7961
11:49 ET10000.79939
11:51 ET4000.7965
11:54 ET24450.7957
11:56 ET1000.7956
12:02 ET1000.7956
12:05 ET13000.7956
12:07 ET1810.7946
12:09 ET18920.7939
12:16 ET1000.7946
12:21 ET1000.7946
12:23 ET4000.7939
12:25 ET1000.79435
12:30 ET1000.794
12:32 ET3000.794
12:38 ET5000.7934
12:45 ET9300.79395
12:52 ET6300.794
12:54 ET57000.7918
12:56 ET2000.7905
12:59 ET1000.79
01:08 ET1000.7922
01:10 ET4000.79
01:21 ET2000.7925
01:30 ET3000.7923
01:32 ET3000.7923
01:35 ET12260.7912
01:37 ET2160.7912
01:42 ET1000.7912
01:48 ET7000.793
01:55 ET4000.7891
01:57 ET4000.791
02:00 ET1000.793
02:04 ET1000.793
02:08 ET2000.793
02:09 ET3340.792299
02:11 ET1000.793
02:13 ET1000.7905
02:20 ET1000.7905
02:22 ET1000.793
02:24 ET7450.7906
02:27 ET1000.793
02:29 ET2000.7906
02:31 ET15690.7852
02:33 ET2000.7807
02:40 ET1000.7852
02:42 ET2000.7852
02:45 ET28000.7816
02:47 ET1090.7822
02:49 ET3000.7852
02:51 ET9940.7828
02:54 ET4810.7864
02:56 ET1260.78966
02:58 ET2000.7899
03:00 ET1000.78695
03:02 ET8450.7899
03:05 ET1000.7899
03:07 ET2000.7899
03:12 ET35000.784851
03:14 ET12460.781
03:18 ET126580.7851
03:20 ET57940.7876
03:21 ET182740.7783
03:23 ET10000.7783
03:27 ET8000.7778
03:30 ET3000.7757
03:34 ET1000.7759
03:38 ET1270.7759
03:39 ET1000.7787
03:41 ET1000.7816
03:43 ET20190.7775
03:45 ET5200.77765
03:48 ET20410.7792
03:50 ET260010.78
03:52 ET84710.7778
03:54 ET6000.7792
03:56 ET9040.7785
03:57 ET134790.7792
03:59 ET2259080.7798
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVERU
Veru Inc
114.2M
-2.3x
---
United StatesSPCO
Stephan Co
4.6M
-0.5x
---
United StatesAXIL
AXIL Brands Inc
32.4M
19.5x
---
United StatesCAWW
CCA Industries Inc
5.3M
-21.9x
---
United StatesNXRA
Nextera Enterprises Inc
40.0
0.0x
---
United StatesMACE
Mace Security International Inc
1.8M
-0.4x
---
As of 2024-09-22

Company Information

Veru Inc. is a biopharmaceutical company. The Company is focused on developing medicines for the for the treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and other viral-related ARDS and for the management of breast and prostate cancers. The Company offers two FDA approved products within its sexual health program, including ENTADFI (tadalafil 5mg and finasteride 5mg capsule), for the treatment of benign prostatic hyperplasia and FC2 Female Condom (internal condom) (FC2), for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. Its breast cancer drug pipeline has four clinical development programs for two drugs, such as enobosarm, an oral selective androgen receptor targeting agonist, and sabizabulin, an oral cytoskeleton disruptor. Its prostate cancer drug pipeline includes sabizabulin, VERU-100 and zuclomiphene citrate.

Contact Information

Headquarters
2916 N. MIAMI AVENUE, SUITE 1000MIAMI, FL, United States 33127
Phone
312-595-9123
Fax
312-595-9122

Executives

Chairman of the Board, President, Chief Executive Officer
Mitchell Steiner
Chief Corporate Officer, Director
Harry Fisch
Chief Financial Officer, Chief Administrative Officer
Michele Greco
Chief Scientific Officer
K. Gary Barnette
Independent Director
Mario Eisenberger

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$114.2M
Revenue (TTM)
$14.1M
Shares Outstanding
146.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.47
EPS
$-0.35
Book Value
$0.21
P/E Ratio
-2.3x
Price/Sales (TTM)
8.1
Price/Cash Flow (TTM)
---
Operating Margin
-281.09%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.